Charles River Laboratories International, Inc. (CRL)
291.50
-4.91
(-1.66%)
USD |
NYSE |
Aug 28, 16:00
291.40
-0.10
(-0.04%)
After-Hours: 20:00
Charles River Laboratories International Cash from Operations (Quarterly) : 179.72M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 179.72M |
| March 31, 2026 | 41.08M |
| December 31, 2025 | 147.52M |
| September 30, 2025 | 213.83M |
| June 30, 2025 | 204.60M |
| March 31, 2025 | 171.70M |
| December 31, 2024 | 159.36M |
| September 30, 2024 | 251.79M |
| June 30, 2024 | 193.54M |
| March 31, 2024 | 129.89M |
| December 31, 2023 | 220.94M |
| September 30, 2023 | 205.45M |
| June 30, 2023 | 148.12M |
| March 31, 2023 | 109.38M |
| December 31, 2022 | 234.76M |
| September 30, 2022 | 132.78M |
| June 30, 2022 | 149.47M |
| March 31, 2022 | 102.63M |
| December 31, 2021 | 229.26M |
| September 30, 2021 | 174.72M |
| June 30, 2021 | 186.59M |
| March 31, 2021 | 170.23M |
| December 31, 2020 | 138.38M |
| September 30, 2020 | 177.30M |
| June 30, 2020 | 162.31M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.59M |
| December 31, 2019 | 180.68M |
| September 30, 2019 | 155.85M |
| June 30, 2019 | 129.55M |
| March 31, 2019 | 14.86M |
| December 31, 2018 | 139.97M |
| September 30, 2018 | 117.24M |
| June 30, 2018 | 123.87M |
| March 31, 2018 | 60.05M |
| December 31, 2017 | 124.24M |
| September 30, 2017 | 59.48M |
| June 30, 2017 | 100.32M |
| March 31, 2017 | 34.03M |
| December 31, 2016 | 114.25M |
| September 30, 2016 | 69.61M |
| June 30, 2016 | 77.98M |
| March 31, 2016 | 38.54M |
| December 31, 2015 | 102.34M |
| September 30, 2015 | 88.29M |
| June 30, 2015 | 86.35M |
| March 31, 2015 | 11.25M |
| December 31, 2014 | 99.85M |
| September 30, 2014 | 66.84M |
| June 30, 2014 | 56.98M |
| March 31, 2014 | 28.46M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 558.00M |
| Medpace Holdings, Inc. | 162.01M |
| Fortrea Holdings, Inc. | 28.90M |
| Avantor, Inc. | 178.20M |
| Champions Oncology, Inc. | -1.998M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 28.10M |
| Cash from Financing (Quarterly) | -164.66M |
| Free Cash Flow | 370.60M |
| Free Cash Flow Per Share (Quarterly) | 3.095 |
| Free Cash Flow to Equity (Quarterly) | 178.83M |
| Free Cash Flow to Firm (Quarterly) | 148.19M |
| Free Cash Flow Yield | 2.60% |